Mercy Health - Clermont Hospital Llc Hospital Units - Psychiatric Unit Medicare: Medicare Enrolled Practice Location: 3000 Hospital Dr, Batavia, OH 45103 Phone: 513-732-8200 Fax: 513-732-8537 |
Mercy Health Clermont Hospital - Intensive Op-anthem Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3000 Hospital Dr, Batavia, OH 45103 Phone: 513-732-8200 |
Restore At A Ray Of Hope Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 33 N Market St, Batavia, OH 45103 Phone: 513-409-3635 Fax: 513-402-0408 |
Clermont County Board Of D.d Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 2040 Us Highway 50, Batavia, OH 45103 Phone: 513-732-7000 Fax: 513-732-7006 |
Clermont County Board Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2040 Us Highway 50, Batavia, OH 45103 Phone: 513-732-7000 Fax: 513-732-7006 |
Resilient Roots Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 55 W Main St, Batavia, OH 45103 Phone: 513-685-3504 |
Neurology Healthcare Llc Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 3020 Hospital Dr, Suite 240, Batavia, OH 45103 Phone: 513-299-1218 |
News Archive
Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.
Swelling of lymph nodes in the armpit area is a normal response to COVID-19 vaccinations, but when they are seen on mammograms, they can be mistaken for nodes that are swollen because of cancer. In some cases, the nodes are biopsied to confirm they are not cancer.
Kentucky is one of the poorest states in the U.S. However, the state has been one of the most successful in reducing its uninsured rate, which happened in part through the Affordable Care Act's Medicaid expansion that took effect on January 1, 2014.
Cardium Therapeutics announced plans to report on preliminary safety and efficacy data from its Matrix Phase 2b Excellarate clinical study. Based on guidance from Cardium's independent clinical data management company which is currently completing the statistical analysis of all data for the Matrix clinical trial, Cardium expects to receive the locked unblinded data set and be in position to announce preliminary results on or before October 14, 2009.
› Verified 4 days ago